Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADIANCE 1: Torcetrapib/Atorvastatin in HeFH
NCT00136981Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2003
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 3, randomised, double-blind trial of torcetrapib in familial hypercholesterolemia (FH) (2 arms), sponsored by Pfizer. Primary endpoint: Change in intima media thickness at 24 months. Started Dec 2003; status: completed.
02
Drugs
torcetrapib
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NCT00136981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136981.